Table 2

HSV shedding rates by HAART status*

OutcomeAntiretroviral-naïve (n=44)HAART-treated (n=41)p Value
HSV (type 1 and/or 2) shedding rate among all participants (n=85)3.6 (0, 10.7)7.1 (0, 17.9)0.28
range 0–33.3range 0–46.4
HSV-1 shedding rate among HSV-1 seropositive participants (n=74)0 (0, 3.6)0 (0, 7.1)0.38
range 0–33.3range 0–35.7
 Oral HSV-1 shedding rate0 (0, 3.6)0 (0, 3.6)0.95
range 0–33.3range 0–21.4
 Anogenital HSV-1 shedding rate0 (0, 0)0 (0, 0)0.06
range 0–4.8range 0–35.7
HSV-2 shedding rate among HSV-2 seropositive participants (n=56)3.6 (0, 10.7)7.1 (0, 14.3)0.47
range 0–33.3range 0–46.4
 Oral HSV-2 shedding rate0 (0, 0)0 (0, 0)0.05
range 0–0range 0–28.6
 Anogenital HSV-2 shedding rate3.6 (0, 10.7)7.1 (0, 10.7)0.55
range 0–33.3range 0–46.4
  • *Values are median (IQR), range.

  • HAART, highly active antiretroviral therapy; HSV, herpes simplex virus.